Provided by Tiger Trade Technology Pte. Ltd.

Jaguar Animal Health

0.8675
-0.0060-0.69%
Volume:76.62K
Turnover:66.81K
Market Cap:4.26M
PE:0.00
High:0.9279
Open:0.8700
Low:0.8247
Close:0.8735
52wk High:77.63
52wk Low:0.7250
Shares:4.91M
Float Shares:4.88M
Volume Ratio:0.20
T/O Rate:1.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-262.2873
EPS(LYR):-803.9466
ROE:-548.83%
ROA:-38.04%
PB:0.64
PE(LYR):0.00

Loading ...

Jaguar Health granted extension to demonstrate compliance with Nasdaq bid rule

TIPRANKS
·
Apr 27

Jaguar Health executes 1-for-35 reverse stock split effective April 30

Reuters
·
Apr 27

Jaguar Health reports acceptance of abstracts on crofelemer for ESPGHAN meeting

TIPRANKS
·
Apr 24

Jaguar Health says two late-breaking pediatric intestinal failure crofelemer abstracts accepted at ESPGHAN

Reuters
·
Apr 24

Jaguar Health plans AI platforms to advance crofelemer clinical development for intestinal failure

Reuters
·
Apr 13

Jaguar Health hosts investor webcast on Q4 2025 financials and company updates

Reuters
·
Apr 10

Jaguar Animal Health Regains Nasdaq Compliance Through Capital Infusions

TIPRANKS
·
Apr 10

Jaguar Health completes effectiveness study of crofelemer tablets

TIPRANKS
·
Apr 08

Jaguar Health completes dog trial to support full FDA approval for Canalevia-CA1

Reuters
·
Apr 08

Jaguar Health FY25 net loss widens 37.6% to $54 million

Reuters
·
Apr 07

Jaguar Health says crofelemer study cuts pediatric intestinal failure parenteral support 12%-37%

Reuters
·
Apr 02

Jaguar Health unit Napo co-sponsors Elite Ped-GI Congress, spotlights crofelemer pediatric IF data

Reuters
·
Apr 02

Jaguar Health delays annual report filing, cites delay compiling material subsequent events

Reuters
·
Apr 02

Jaguar Health to start single-blind extension phase in crofelemer trial for pediatric MVID patients

Reuters
·
Mar 18

Jaguar Health CEO Lisa Conte to present at Life Sciences Virtual Investor Forum

Reuters
·
Mar 11

Jaguar Animal Health Restructures Debt and Royalty Agreements

TIPRANKS
·
Mar 09

Jaguar Health Inc - Amends Uptown 2020 Royalty Interest; Repayment Amount Reduced to $11.1 Mln - SEC Filing

THOMSON REUTERS
·
Mar 09

Jaguar Health amends Streeterville promissory notes and extends 2025 note maturity to 2029

Reuters
·
Mar 09

Jaguar Health restructures Chicago Venture Partners debt and cuts obligations by about 10% to reduce roughly USD 3 million

Reuters
·
Mar 09

Nasdaq flags Jaguar Health for sub-$1 bid price listing rule breach

Reuters
·
Mar 07